GLGi Su Lee

Gi Su Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gi Su Lee has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Glycosylated Hemoglobin Levels in the Third Trimester for Predicting Adverse Pregnancy and Neonatal Outcomes in Women with Pre-Gestational Diabetes: A Multi-Center Retrospective Cohort Study in South Korea

    by Su-Yeon Park, Mi-Ju Kim, Su-Been Hong, Ji-Hee Sung, Hyun-Joo Seol, Joon-Ho Lee, Seung-Chul Kim, Seung-Mi Lee, Se-Jin Lee, Han-Sung Hwang, et al.

    Background/Objectives: The objective of this study is to investigate pregnancy and neonatal outcomes in women with pre-gestational diabetes (PGDM) in the Korean population and compare outcomes according to glycosylated hemoglobin (HbA1c) levels in the third trimester. Methods: Singleton pregnant women with PGDM, with follow-up data, and who delivered at 16 Korean tertiary institutions between 2010 and 2023 were included for analysis. Eligible patients were divided into two groups according to HbA1c levels (47.5 mmol/mol, 6.5%) in the third trimester (well-controlled and poorly controlled group). Adverse pregnancy and neonatal outcomes between the two groups were compared. The primary outcome was the composite neonatal adverse outcome and the secondary outcome was pregnancy-related hypertension. Results: In 416 pregnancies, the mean HbA1c in the third trimester was 45 mmol/mol (6.26%). Of these, 296 (71.2%) women were included in the well-controlled group and 120 (28.8%) in the poorly controlled group. Between these, the poorly controlled group showed a significantly higher risk of composite neonatal adverse outcome (57.8% vs. 79.2%, p < 0.001) and pregnancy-related hypertension (14.5% vs. 24.2%, p = 0.022). In multivariate analysis, HbA1c > 6.5% in the third trimester was associated with higher risk of composite neonatal adverse outcome and pregnancy-related hypertension. HbA1c ROC curves for the third trimester that predicted composite neonatal adverse outcomes had an AUC of 0.66; HbA1c of 43.7 mmol/mol (6.15%) had a sensitivity of 52.3% and specificity of 73.5% (p < 0.001). Conclusions: In PGDM, HbA1c > 47.5 mmol/mol (6.5%) in the third trimester was significantly associated with a higher risk of adverse neonatal and pregnancy outcomes and could be a predictive factor for composite neonatal adverse outcomes and pregnancy-related hypertension. Maintenance of HbA1c levels below 43.7 mmol/mol (6.15%) in the third trimester might decrease the risk of adverse neonatal outcomes.


  • Open Access

    Role of Cervical Elastography in Predicting Progression to Active Phase in Labor Induction in Term Nulliparous Women

    by Su-Jung Hong, Young-Mi Jung, Jeong-Eun Hwang, Ki-Su Lee, Geum-Joon Cho, Min-Jeong Oh

    Background/Objectives: Several factors, such as age, parity, body mass index, a favorable cervix, and fetal birth weight, are known to be related to the success of labor induction. With advancements in ultrasound technology, these factors have been studied to predict the success of vaginal delivery. However, there has been limited research on ultrasound measures that can effectively predict entry into the active phase of labor. Thus, we aimed to assess the use of cervical quantitative strain sonoelastography to predict entry into the active phase of labor induction. Methods: This prospective study included nulliparous term singleton pregnant women scheduled for labor induction between July 2018 and July 2022. Sonographic parameters were obtained using a transvaginal ultrasound approach with semiautomatic quantitative strain elastography software (E-Cervix; Samsung WS80A ultrasound device with a VR5-9 transducer, Samsung Medison Co., Ltd., Seoul, Republic of Korea), which provides objective measurements through the pixel-based analysis of elastographic maps. Univariate and multivariate logistic regression and area-under-the-curve analyses were used to evaluate the diagnostic performance of the variables under consideration in predicting the onset of the active phase of labor. Results: A total of 71 women were included in the study, and 29 progressed to the active phase. The cervical length, angle of progression, and mean strain from the external cervical os were significantly associated with successful entry into the active phase. The receiver operating characteristic (ROC) curve model also indicated a higher predictive value when the elastographic parameters were combined. Conclusions: Cervical elastography can be used as a sonographic index to predict progression to the active phase of labor.


  • Open Access

    Maternal and Neonatal Outcomes Based on Changes in Glycosylated Hemoglobin Levels During First and Second Trimesters of Pregnancy in Women with Pregestational Diabetes: Multicenter, Retrospective Cohort Study in South Korea

    by Mi Ju Kim, Suyeon Park, Sooran Choi, Subeen Hong, Ji-Hee Sung, Hyun-Joo Seol, Joon Ho Lee, Seung Cheol Kim, Sae-Kyoung Choi, Ji Young Kwon, et al.

    This study compared glycosylated hemoglobin (HbA1c) levels in the first and second trimesters of pregnancy and assessed maternal and neonatal outcomes according to HbA1c variations among women with pregestational diabetes. This retrospective, multicenter Korean study involved mothers with diabetes who had given birth in 17 hospitals. A total of 292 women were divided into three groups based on HbA1c levels during the first and second trimesters: women with HbA1c levels maintained at <6.5% (well-controlled [WC] group); women with HbA1c ≥ 6.5% (poorly-controlled [PC] group); and women with HbA1c ≥ 6.5% in the first trimester but <6.5% in the second trimester (improved-control [IC] group). The PC group had the highest pregnancy-associated hypertension (PAH) incidence, while the incidence did not significantly differ between the WC and IC groups. The receiver operating characteristic (ROC) curve indicated that HbA1c in the second trimester could predict PAH with a cut-off value of 5.7%. The PC versus WC versus IC group showed statistically significantly higher neonatal birthweight and significantly higher rates of large for gestational age (LGA); however, those were not significantly different between the WC and IC groups. HbA1c levels in the second trimester could predict LGA, with a cut-off value of 5.4%. Therefore, the second trimester HbA1c levels were significantly associated with both maternal and neonatal outcomes.


  • Open Access

    Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?

    by Changho Song, Kyoung Bo Kim, Gi Su Lee, Soyoung Shin, Byoungje Kim

    Endometrial cancer (EC) is one of the most pervasive malignancies in females worldwide. HOXA5 is a member of the homeobox (HOX) family and encodes the HOXA5 protein. HOXA5 is associated with various cancers; however, its association with EC remains unclear. This study aimed to determine the association between HOXA5 gene expression and the prognosis of endometrioid adenocarcinoma, a subtype of EC (EAEC). Microarray data of HOXA5 were collected from the Gene Expression Omnibus datasets, consisting of 79 samples from GSE17025 and 20 samples from GSE29981. RNA-sequencing, clinical, and survival data on EC were obtained from The Cancer Genome Atlas cohort. Survival analysis revealed that HOXA5 overexpression was associated with poor overall survival in patients with EAEC (p = 0.044, HR = 1.832, 95% CI = 1.006–3.334). Cox regression analysis revealed that HOXA5 was an independent risk factor for poor prognosis in EAEC. The overexpression of HOXA5 was associated with a higher histological grade of EAEC, and it was also associated with TP53 mutation or the high copy number of EC. Our findings suggest the potential of HOXA5 as a novel biomarker for predicting poor survival outcomes in patients with EAEC.